Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kyntra Bio (KYNB) Total Debt (2020 - 2025)

Historic Total Debt for Kyntra Bio (KYNB) over the last 4 years, with Q2 2025 value amounting to $73.7 million.

  • Kyntra Bio's Total Debt rose 173.16% to $73.7 million in Q2 2025 from the same period last year, while for Jun 2025 it was $73.7 million, marking a year-over-year increase of 173.16%. This contributed to the annual value of $73.1 million for FY2024, which is 160.98% up from last year.
  • Per Kyntra Bio's latest filing, its Total Debt stood at $73.7 million for Q2 2025, which was up 173.16% from $73.4 million recorded in Q1 2025.
  • In the past 5 years, Kyntra Bio's Total Debt registered a high of $73.7 million during Q2 2025, and its lowest value of $71.4 million during Q2 2023.
  • Over the past 3 years, Kyntra Bio's median Total Debt value was $72.5 million (recorded in 2024), while the average stood at $72.5 million.
  • Per our database at Business Quant, Kyntra Bio's Total Debt skyrocketed by 149.84% in 2024 and then soared by 173.16% in 2025.
  • Quarter analysis of 3 years shows Kyntra Bio's Total Debt stood at $71.9 million in 2023, then grew by 1.61% to $73.1 million in 2024, then increased by 0.88% to $73.7 million in 2025.
  • Its Total Debt stands at $73.7 million for Q2 2025, versus $73.4 million for Q1 2025 and $73.1 million for Q4 2024.